EDAP

Edap Tms

Healthcare Medical Distribution NASDAQ

About the company

Edap TMS SA is a well-established multinational holding company that operates in three distinct divisions: HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. Each division plays a vital role in the company's overall success and contributes to its diverse portfolio of innovative medical technologies. The HIFU division is at the forefront of developing, manufacturing, and marketing devices that utilize HIFU technology for the invasive destruction of certain types of tumors. This groundbreaking technology has revolutionized the medical field by offering a non-invasive and precise method of tumor ablation. Edap TMS SA proudly presents three flagship devices under its HIFU division: Ablatherm, Ablatherm Fusion, and the Focal One. These devices have received global recognition for their ability to treat patients suffering from prostate cancer, uterine fibroids, and other localized tumors. The ESWL division focuses on manufacturing, marketing, and servicing its installed base of Sonolith lithotripters. Lithotripsy, a non-invasive procedure, utilizes shockwaves to fragment kidney stones and provide relief to patients suffering from urinary tract stones. With a commitment to innovation and excellence, Edap TMS SA continuously enhances its Sonolith range of lithotripters to ensure efficiency, accuracy, and patient comfort during the treatment process. The Distribution division serves as the strategic arm of Edap TMS SA, catering to the global market by offering a wide range of complementary medical products. These products include lasers, micro-ultrasound systems, and various medical devices from third-party manufacturers. By expanding its distribution network, Edap TMS SA ensures that healthcare professionals worldwide have access to the latest advancements in medical technology, delivering better patient outcomes. Geographically, Edap TMS SA has established a strong presence in four key regions: Asia, France, the United States, and other international markets. This expansive global reach enables the company to collaborate with medical professionals, academic institutions, and research centers around the world. By fostering collaboration and knowledge sharing, Edap TMS SA stays at the forefront of medical advancements and ensures that its products are tailored to meet the specific needs of healthcare providers in different regions. In conclusion, Edap TMS SA is a leading holding company with a diverse range of medical technologies. Through its HIFU, ESWL, and Distribution divisions, the company provides cutting-edge solutions for tumor ablation, lithotripsy, and complementary medical products. With a global presence and commitment to innovation, Edap TMS SA continues to shape the future of medical care, improving the lives of patients worldwide.

Website: https://focalone.com

Data updated: June 2, 2026

Sector comparison

We compare this company with the typical (middle) company in the same industry to show how it looks against similar businesses. This is information, not a recommendation.

Healthcare · 1346 peers in sector

Metric EDAP Sector median Vs. industry
P/E - 20.10
EPS -0.82 USD -1.14 USD ↑ Above average
Dividend yield 0.00% 0.00%
Profit margin -41.70% 0.00% ↓ Below average
ROE -1.24% -58.84% ↓ Below average

Higher and lower here are only a comparison with the typical company in the industry — a higher or lower value on its own does not mean better or worse.

Financial statements & historical data

Income statements, balance sheets, cash flow, earnings and dividend history are available for registered users

Sign up for free

AI Summary

AI-generated company analysis is available for registered users.

Sign up for free

Where does this data come from?

Frequently Asked Questions

What is Edap Tms?
Edap TMS SA is a well-established multinational holding company that operates in three distinct divisions: HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. Each division plays a vital role in the company's overall success and contributes to its diverse portfolio of innovative medical technologies. The HIFU division is at the forefront of developing, manufacturing, and marketing devices that utilize HIFU technology for the invasive destruction of certain types of tumors. This groundbreaking technology has revolutionized the medical field by offering a non-invasive and precise method of tumor ablation. Edap TMS SA proudly presents three flagship devices under its HIFU division: Ablatherm, Ablatherm Fusion, and the Focal One. These devices have received global recognition for their ability to treat patients suffering from prostate cancer, uterine fibroids, and other localized tumors. The ESWL division focuses on manufacturing, marketing, and servicing its installed base of Sonolith lithotripters. Lithotripsy, a non-invasive procedure, utilizes shockwaves to fragment kidney stones and provide relief to patients suffering from urinary tract stones. With a commitment to innovation and excellence, Edap TMS SA continuously enhances its Sonolith range of lithotripters to ensure efficiency, accuracy, and patient comfort during the treatment process. The Distribution division serves as the strategic arm of Edap TMS SA, catering to the global market by offering a wide range of complementary medical products. These products include lasers, micro-ultrasound systems, and various medical devices from third-party manufacturers. By expanding its distribution network, Edap TMS SA ensures that healthcare professionals worldwide have access to the latest advancements in medical technology, delivering better patient outcomes. Geographically, Edap TMS SA has established a strong presence in four key regions: Asia, France, the United States, and other international markets. This expansive global reach enables the company to collaborate with medical professionals, academic institutions, and research centers around the world. By fostering collaboration and knowledge sharing, Edap TMS SA stays at the forefront of medical advancements and ensures that its products are tailored to meet the specific needs of healthcare providers in different regions. In conclusion, Edap TMS SA is a leading holding company with a diverse range of medical technologies. Through its HIFU, ESWL, and Distribution divisions, the company provides cutting-edge solutions for tumor ablation, lithotripsy, and complementary medical products. With a global presence and commitment to innovation, Edap TMS SA continues to shape the future of medical care, improving the lives of patients worldwide.
How big is Edap Tms?
The market capitalization of Edap Tms — the combined value of all its shares — is 161.9 M USD. The higher the market cap, the larger the company. (as of 2026-06-02)
Does Edap Tms pay dividends?
The dividend yield of Edap Tms is 0.00% — it shows the annual dividend relative to the share price. This is information, not a recommendation. (as of 2026-06-02)
What sector does Edap Tms belong to?
Edap Tms operates in the Healthcare sector, industry: Medical Distribution.

What do you gain?

With Ecrumen you gain full control over your investments and assets!

All your assets
Stock market investments, real estate, bonds. Be aware of what you have in your portfolio!
AI at the service of your investments
Analyze and optimize your investments using the latest technologies. Sentiments, analyses, tips, reports. Always with up-to-date data!
A community eager to help
Find a place with people similar to you. Share your opinions, see how others manage their investments. Get help with the problems that bother you!
What do you gain?

Want to stay up to date?

Subscribe to our newsletter to stay up to date with Ecrumena news and market information. No spam, unsubscribe in one click.

For more information, please refer to our terms of use.

0/120